Posts Tagged: "Zomig®"

Nasal Spray Patents Covering Migraine Drug Zomig Not Invalid As Obvious

The sole question on appeal was whether it would have been obvious to make zolmitriptan into a nasal spray. The Federal Circuit agreed with the district court that the prior art taught away from formulating zolmitriptan for intranasal administration.

Robert Schaffer & Joseph Robinson

July 13, 2018

Posts Tagged: "Zomig®"

Varsity Sponsors

Latest IPW Posts

USPTO Proposes Making Director Review Process Official

Thaler, Copyright Office Fight Over Human-Authorship Requirement for AI-Created Artwork Continues

Evolving IP: The Innovation Crossroads

Federal Circuit Says District Court Erred in Assessing Inequitable Conduct in Toddler Dining Mat Patent Case

Other Barks & Bites for Friday, April 12: Bill to Rein in GAI Introduced; Amazon Owes Tech Rival $525 Million for Patent Infringement; USPTO Issues Guidance on the Use of AI for Filings

IPWatchdog Events

Webinar: Supercharging IP with AI – Deploying Artificial Intelligence While Avoiding the Pitfalls

Webinar – Sponsored by UnitedLex

Webinar – Sponsored by Quartz IP

Patent Litigation Masters™ 2024

Webinar – Sponsored by LexisNexis

From IPWatchdog